Related content

Low‐dose combination of flutamide, metformin and an oral contraceptive for non‐obese, young women with polycystic ovary syndrome

By Ibáñez Lourdes  

Human Reproduction, Vol. 18, Iss. 1, 2003-01 ,pp. : 57-60

Oxford University Press

Access to resources Recommend Favorite

Increased follistatin levels after oral contraceptive treatment in obese and non-obese women with polycystic ovary syndrome

By Chen Mei-Jou   Yang Wei-Shiung   Chen Hsin-Fu   Kuo Jahn-Jahn   Ho Hong-Nerng   Yang Yu-Shih   Chen Shee-Uan  

Human Reproduction, Vol. 25, Iss. 3, 2010-03 ,pp. : 779-785

Oxford University Press

Access to resources Recommend Favorite

Metformin versus flutamide in the treatment of metabolic consequences of non-obese young women with polycystic ovary syndrome: a randomized prospective study

By Sahin I   Serter R   Karakurt F   Demirbas B   Culha C   Taskapan C   Kosar F   Aral Y  

Gynecological Endocrinology, Vol. 19, Iss. 3, 2004-09 ,pp. : 115-124

Informa Healthcare

Access to resources Recommend Favorite

Reproductive endocrinology. Insulin sensitivity in non-obese women with polycystic ovary syndrome during treatment with oral contraceptives containing low-androgenic progestin

By Cibula D.  

Human Reproduction, Vol. 17, Iss. 1, 2002-01 ,pp. : 76-82

Oxford University Press

Access to resources Recommend Favorite

Metformin versus oral contraceptive pill in polycystic ovary syndrome: a Cochrane review

By Costello Michael F.   Shrestha Bhushan   Eden John   Johnson Neil P.   Sjoblom Peter  

Human Reproduction, Vol. 22, Iss. 5, 2007-05 ,pp. : 1200-1209

Oxford University Press

Access to resources Recommend Favorite